levodopa

FDA Drug Profile — Inbrija

levodopa is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including Inbrija. Available dosage forms: capsule, powder.

Drug details

Generic Name
levodopa
Brand Names
Inbrija
Application Number
NDA209184
Sponsor
Merz Pharmaceuticals, LLC
NDC Codes
6
Dosage Forms
CAPSULE, POWDER
Routes
RESPIRATORY (INHALATION)
Active Ingredients
LEVODOPA

Indications and Usage

1 INDICATIONS AND USAGE INBRIJA is indicated for the intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa. INBRIJA is an aromatic amino acid indicated for the intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.